Extracellular adenosine triphosphate induces glutamate transporter-1 expression in hippocampus

Hippocampus

Volumn 17, Issue 4, 2007, Pages 305-315

  Frizzo, Marcos E ^a,b,c   Frizzo, Juliana K ^a,b   Amadio, Susanna ^a,d   Rodrigues, Juliana M ^b   Perry, Marcos L ^b   Bernardi, Giorgio ^a,d   Volonté, Cinzia ^a,e  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b Instituto de Ciencias Biologicas e da Saude Pontifical Catholic University of Minas Gerais   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e CNR   (Italy)

Author keywords

Astrocyte; ERK; GLT1; Hippocampal slices; P2 receptors

Indexed keywords

ADENOSINE TRIPHOSPHATE; EXCITATORY AMINO ACID TRANSPORTER 1; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PURINE RECEPTOR; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FOREBRAIN; HIPPOCAMPUS; MOLECULAR INTERACTION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BUTADIENES; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; EXCITATORY AMINO ACID TRANSPORTER 2; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; HIPPOCAMPUS; MALE; NITRILES; RATS; RATS, WISTAR;

EID: 34247545591     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20269     Document Type: Article

References (58)

1. Abbracchio MP, Saffrey MJ, Hopker V, Burnstock G. 1994. Modulation of astroglial cell proliferation by analogues of adenosine and ATP in primary cultures of rat striatum. Neuroscience 59:67-76.
2. Agrawal SK, Fehlings MG. 1997. Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury. J Neurosci 17:1055-1063.
3. Ahmed SM, Rzigalinski BA, Willoughby KA, Sitterding HA, Ellis EF. 2000. Stretch-induced injury alters mitochondrial membrane potential and cellular ATP in cultured astrocytes and neurons. J Neurochem 74:1951-1960.
4. Amadio S, D'Ambrosi N, Cavaliere F, Murra B, Sancesario G, Bernardi G, Burnstock G, Volonté C. 2002. P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology 42:489-501.
5. Anderson CM, Swanson RA. 2000. Astrocyte glutamate transport: Review of properties, regulation, and physiological functions. Glia 32:1-14.
6. Attwell D, Barbour B, Szatkowski M. 1993. Nonvesicular release of neurotransmitter. Neuron 11:401-407.
7. Bodin P, Milner P, Winter R, Burnstock G. 1992. Chronic hypoxia changes the ratio of endothelin to ATP release from rat aortic endothelial cells exposed to high flow. Proc R Soc Lond B Biol Sci 247:131-135.
8. Bolego C, Ceruti S, Brambilla R, Puglisi L, Cattabeni F, Burnstock G, Abbracchio MP. 1997. Characterization of the signalling pathways involved in ATP, basic fibroblast growth factor-induced astrogliosis. Br J Pharmacol 121:1692-1699.
9. Bonde C, Sarup A, Schousboe A, Gegelashvili G, Noraberg J, Zimmer J. 2003. GDNF pre-treatment aggravates neuronal cell loss in oxygen-glucose- deprived hippocampal slice cultures: A possible effect of glutamate transporter up-regulation. Neurochem Int 43:381-388.
10. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
11. Burnstock G. 2006a. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58:58-86.
12. Burnstock G. 2006b. Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 27:166-176.
13. Burnstock G, Knight GE. 2004. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240:31-304.
14. Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH, Sofroniew MV. 1999. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23:297-308.
15. Cavaliere F, Amadio S, Sancesario G, Bernardi G, Volonté C. 2004a. Synaptic P2X7 and oxygen/glucose deprivation in hippocampal organotypic cultures. J Cereb Blood Flow Metab 24:392-398.
16. 4 receptor during hypoglycemia: Cross talk with the ionotropic NMDAR1 receptor. Exp Cell Res 300:149-158.
17. Cavaliere F, Nestola V, Amadio S, D'Ambrosi N, Angelini DF, Sancesario G, Bernardi G, Volonté C. 2005. The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells. Neurobiol Dis 18: 100-109.
18. Danbolt NC. 2001. Glutamate uptake. Prog Neurobiol 65:1-105.
19. Duan S, Anderson CM, Stein BA, Swanson R. 1999. Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J Neurosci 19:10193-10200.
20. Franke H, Krügel U, Illes P. 1999. P2 receptor-mediated proliferative effects on astrocytes in vivo. Glia 28:190-200.
21. Frotscher M, Kugler P, Misgeld U, Zilles K. 1988. Neurotransmission in the hippocampus. Adv Anat Embryol Cell Biol 111:1-103.
22. Gegelashvili G, Schousboe A. 1997. High-affinity glutamate transporters: Regulation of expression and activity. Mol Pharmacol 52:6-15.
23. Gegelashvili G, Civenni G, Racagni G, Danbolt NC, Schousboe I, Schousboe A. 1996. Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes. NeuroReport 8:261-265.
24. Gegelashvili G, Dehnes Y, Danbolt NC, Schousboe A. 2000. The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms. Neurochem Int 37:163-170.
25. Gomi H, Yokoyama T, Fujimoto K, Ikeda T, Katoh A, Itoh T, Itohara S. 1995. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron 14:29-41.
26. Haghighi SS, Johnson GC, de Vergel CF, Vergel-Rivas BJ. 1996. Pretreatment with NMDA receptor antagonist MK801 improves neurophysiological outcome after an acute spinal cord injury. Neurol Res 18:509-515.
27. + signalling in glial cell pathology in the central nervous system. Eur J Pharmacol 447:247-260.
28. Jeremic A, Jeftinija K, Stevanovic J, Glavaski A, Jeftinija S. 2001. ATP stimulates calcium-dependent glutamate release from cultured astrocytes. J Neurochem 77:664-675.
29. Kondo K, Hashimoto H, Kitanaka J, Sawada M, Suzumura A, Marunouchi T, Baba A. 1995. Expression of glutamate transporters in cultured glial cells. Neurosci Lett 188:140-142.
30. Kugler P, Schleyer V. 2004. Developmental expression of glutamate transporters and glutamate dehydrogenase in astrocytes of the postnatal rat hippocampus. Hippocampus 14:975-985.
31. Lee JM, Zipfel GJ, Choi DW. 1999. The changing landscape of ischemic brain injury mechanisms. Nature 399:7-14.
32. Lehre KP, Danbolt NC. 1998. The number of glutamate transporter subtype molecules at glutamatergic synapses: Chemical and stereological quantification in young adult rat brain. J Neurosci 18:8751-8757.
33. Matthias K, Kirchhoff F, Seifert G, Hüttmann K, Matyash M, Kettenmann H, Steinhäuser C. 2003. Segregated expression of AMPA-type glutamate receptors and glutamate transporters defines distinct astrocyte populations in the mouse hippocampus. J Neurosci 231:750-1758.
34. Melani A, Turchi D, Vannucchi MG, Cipriani S, Gianfriddo M, Pedata F. 2005. ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem Int 47:442-448.
35. Meldrum BS. 2000. Glutamate as a neurotransmitter in the brain: Review of physiology and pathology. J Nutr 130:1007-1015.
36. Merlo D, Volonté C. 1996. Binding and functions of extracellular ATP in cultured cerebellar granule neurons. Biochem Biophys Res Commun 255:907-914.
37. Michetti F, Gazzolo D. 2002. S100B protein in biological fluids: A tool for perinatal medicine. Clin Chem 48:2097-2104.
38. Neary JT, Abbracchio MP. 2001. Trophic roles of purines and pyrimidines. In: Williams M, Abbracchio MP, editors. Handbook of Experimental Pharmacology: Purinergic and Pyrimidergic Signalling. New York: Springer. pp 305-338.
39. Neary JT, Kang Y, Bu Y, Yu E, Akong K, Peters CM. 1999. Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: Involvement of a calcium-independent protein kinase C, extracellular signal regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C, calcium pathway. J Neurosci 19:4211-4220.
40. Neary JT, Kang Y, Willoughby KA, Ellis EF. 2003. Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP, P2 purinergic receptors. J Neurosci 23: 2348-2356.
41. Nedergaard M, Dirnagl U. 2005. Role of glial cells in cerebral ischemia. Glia 50:281-286.
42. Noraberg J, Kristensen BW, Zimmer J. 1999. Markers for neuronal degeneration in organotypic slice cultures. Brain Res Brain Res Protoc 3:278-290.
43. Phillis JW, Ren J, O'Regan MH. 2000. Transporter reversal as mechanism of glutamate release from the ischemic rat cerebral cortex: Studies with D,L-threo-b-benzyloxyaspartate. Brain Res 868:105-112.
44. Rathbone MP, Middlemiss PJ, Kim J-L, Gysbers JW, DeForge SP, Smith RW, Hughes DW. 1992. Adenosine and its nucleotides stimulate proliferation of chick astrocytes and human astrocytoma cells. Neurosci Res 13:1-17.
45. Ray SK, Dixon CE, Banik NL. 2002. Molecular mechanisms in the pathogenesis of traumatic brain injury. Histol Histopathol 17:1137-1152.
46. +- dependent glutamate transporters by cAMP analogs and neurons. Mol Pharmacol 53:355-369.
47. Seki Y, Feustel PJ, Keller RW Jr, Tranmer BI, Kimelberg HK. 1999. Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker. Stroke 30:433-440.
48. Swanson RA, Liu J, Miller JW, Rothstein JD, Farrel K, Stein BA, Longuemare MC. 1997. Neuronal regulation of glutamate transporter subtype expression in astrocytes. J Neurosci 17:932-940.
49. Van Eldik L, Wainwright MS. 2003. The Janus face of glial-derived S100B: Beneficial and detrimental functions in the brain. Restor Neurol Neurosci 21:97-108.
50. 2 purinoceptor modulators prevent glutamate-evoked cytotoxicity in cultured cerebellar granule neurons. J Neurosci Res 45:183-193.
51. Volonté C, Ciotti MT, D'Ambrosi N, Lockhart B, Spedding M. 1999. Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurons. Neuropharmacology 38:1335-1342.
52. Volonté C, Amadio S, Cavaliere F, D'Ambrosi N, Vacca F, Bernardi G. 2003. Extracellular ATP, neurodegeneration. Curr Drug Targets CNS Neurol Disord 2:403-412.
53. Volonte C, Amadio S, D'Ambrosi N, Colpi M, Burnstock G. 2006. P2 receptor web: Complexity and fine-tuning. Pharmacol Ther 112:264-280.
54. Wang X, Messing A, David S. 1997. Axonal and nonneuronal cell responses to spinal cord injury in mice lacking glial fibrillary acidic protein. Exp Neurol 148:568-576.
55. Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P, Li P, Xu Q, Liu QS, Goldman SA, Nedergaard M. 2004. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10:821-827.
56. Yang L, Cranson D, Trinkaus-Randall V. 2004. Cellular injury induces activation of MAPK via P2Y receptors. J Cell Biochem 91:938-950.
57. Zelenaia O, Schlag BD, Gochenauer GE, Ganel R, Song W, Beesley JS, Grinspan JB, Rothstein JD, Robinson MB. 2000. Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kB. Mol Pharmacol 57:667-678.
58. Zou JY, Crews FT. 2005. TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: Neuroprotection by NFkB inhibition. Brain Res 1034:11-24.